Welcome to CDC Stacks | A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks - 34824 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks
Filetype[PDF - 2.33 MB]


Details:
No Related Documents.
You May Also Like:
  1. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis
    Personal Author:
    Chen, Sidi; Sanjana, Neville E.; Zheng, Kaijie; Shalem, Ophir; Lee, Kyungheon; Shi, Xi; Scott, David A.; Song, Jun; Pan, Jen Q.; Weissleder, Ralph; Lee, Hakho; Zhang, Feng; Sharp, Phillip A.;
    Published:
    Mar 05 2015
    Source:
    Cell. 2015; 160(6):1246-1260.
    Description:
    Genetic screens are powerful tools for identifying genes responsible for diverse phenotypes. Here we describe a genome-wide CRISPR/Cas9-mediated loss-of-function screen in tumor growth and metastasis. We mutagenized a non-metastatic mouse cancer cell...
    File Type:
    Filetype[PDF - 2.36 MB]
  2. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
    Personal Author:
    Wu, Xuebing; Scott, David A.; Kriz, Andrea J.; Chiu, Anthony C.; Hsu, Patrick D.; Dadon, Daniel B.; Cheng, Albert W.; Trevino, Alexandro E.; Konermann, Silvana; Chen, Sidi; Jaenisch, Rudolf; Zhang, Feng; Sharp, Phillip A.;
    Published:
    Apr 20 2014
    Source:
    Nat Biotechnol. 32(7):670-676.
    Description:
    Bacterial type II CRISPR-Cas9 systems have been widely adapted for RNA-guided genome editing and transcription regulation in eukaryotic cells, yet their in vivo target specificity is poorly understood. Here we mapped genome-wide binding sites of a ca...
    File Type:
    Filetype[PDF - 1.31 MB]
  3. Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell Growth
    Personal Author:
    Wallace, Jared; Hu, Ruozhen; Mosbruger, Timothy L.; Dahlem, Timothy J.; Stephens, W. Zac; Rao, Dinesh S.; Round, June L.; O’Connell, Ryan M.;
    Published:
    Apr 15 2016
    Source:
    PLoS One. 2016; 11(4).
    Description:
    Mammalian microRNA expression is dysregulated in human cancer. However, the functional relevance of many microRNAs in the context of tumor biology remains unclear. Using CRISPR-Cas9 technology, we performed a global loss-of-function screen to simulta...
    File Type:
    Filetype[PDF - 825.94 KB]
  4. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
    Personal Author:
    Shalem, Ophir; Sanjana, Neville E.; Hartenian, Ella; Shi, Xi; Scott, David A.; Mikkelson, Tarjei; Heckl, Dirk; Ebert, Benjamin L.; Root, David E.; Doench, John G.; Zhang, Feng;
    Published:
    Dec 12 2013
    Source:
    Science. 343(6166):84-87.
    Description:
    The simplicity of programming the CRISPR (clustered regularly interspaced short palindromic repeats)-associated nuclease Cas9 to modify specific genomic loci suggests a new way to interrogate gene function on a genome-wide scale. We show that lentivi...
    File Type:
    Filetype[PDF - 919.95 KB]
  5. GENOME EDITING IN HUMAN CELLS USING CRISPR/CAS NUCLEASES
    Personal Author:
    Wyvekens, Nicolas; Tsai, Shengdar; Joung, J. Keith;
    Published:
    Oct 01 2015
    Source:
    Curr Protoc Mol Biol. 112:31.3.1-31.318.
    Description:
    The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system has been broadly adopted for highly efficient genome editing in a variety of model organisms and human cell types. Unlike previous genome editing tec...
    File Type:
    Filetype[PDF - 1.05 MB]